Myomo Introduces Myomo Mobile App

Myomo Inc. has launched the Myomo Mobile App, a new digital tool designed to support clinicians and patients throughout the MyoPro experience.

The Myomo Mobile App aims to make MyoPro care more intuitive, more connected, and more data-informed. For clinicians, the app provides a streamlined mobile interface for customizing EMG settings in person or remotely, including gain, threshold, range of motion, and advanced settings. It also gives clinicians visibility into patient usage and device configurations, helping support more proactive follow-up and care management.

“For clinicians, the Myomo Mobile App is designed to simplify device configuration and improve visibility into patient use, whether care is delivered in clinic or remotely,” Myomo Chairman/CEO Paul R. Gudonis stated. “For patients, the app helps make muscle activity more understandable and encourages confidence through real-time feedback and easy access to training resources.”

For patients, the app provides real-time insight into muscle activity during daily use, allowing users to view EMG signals and track repetitions at home or on the go. New visualizations are designed to mirror device movement and display the mode, helping patients better understand the way MyoPro responds to their muscle activity. The app also offers quick access to training materials and support resources to encourage independent self-management and continued progress.

Built on a modern digital infrastructure, the Myomo Mobile App supports stronger data capture, expanded performance analytics, and supports the development of future product capabilities. The app reflects the company’s broader commitment to improving the user experience for clinicians, caregivers, and patients across clinical and throughout patients’ daily lives, executives claim.

Myomo Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets MyoPro, a powered upper-limb orthosis for supporting the arm and restoring function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, or other neuromuscular disease or injury. It reportedly is the only marketed U.S. device that by sensing a patient’s own EMG signals through non-invasive arm sensors, can restore the user’s ability to perform daily living activities, including feeding themselves, carrying objects, and conducting household tasks. Many can return to work, live independently, and reduce their care costs. Myomo is headquartered in Burlington, Mass., with sales and clinical professionals across the United States and representatives internationally.